Glycoprotein 60 diversity in C. hominis and C. parvum causing human cryptosporidiosis in NSW, Australia.
Management and control of cryptosporidiosis in human requires knowledge of Cryptosporidium species contributing to human disease. Markers that are able to provide information below the species level have become important tools for source tracking. Using the hypervariable surface antigen, glycoprotein 60 (GP60), C. hominis (n=37) and C. parvum (n=32) isolates from cryptosporidiosis cases in New South Wales, Australia, were characterised. Extensive variation was observed within this locus and the isolates could be divided into 8 families and 24 different subtypes. The subtypes identified have global distributions and indicate that anthroponotic and zoonotic transmission routes contribute to sporadic human cryptosporidiosis in NSW.
Waldron
L S
LS
Department of Biological Sciences, Macquarie University, Sydney, NSW 2109, Australia. lwaldron@bio.mq.edu.au
Ferrari
B C
BC
Power
M L
ML
D000818:Animals; D003001:Cloning, Molecular; D003457:Cryptosporidiosis / Q000469:parasitology*; D003458:Cryptosporidium / Q000145:classification / Q000235:genetics*; D016785:Cryptosporidium parvum / Q000145:classification / Q000235:genetics*; D016054:DNA, Protozoan / Q000737:chemistry / Q000302:isolation & purification; D005243:Feces / Q000469:parasitology; D014644:Genetic Variation; D005838:Genotype; D006023:Glycoproteins / Q000235:genetics*; D006801:Humans; D009517:New South Wales; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA
D016054:DNA, Protozoan; D006023:Glycoproteins